BUZZ-Catamaran Corp: Profit, revenue beat estimates

Thu Oct 30, 2014 11:14am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Pharmacy benefit manager's U.S.-listed and Toronto-listed shares up 9 pct

** Revenue, profit beat analysts' average estimates after the company added customers and inclusion of Restat acquisition

** Q3 revenue rises more than 50 pct to $5.54 billion, beating analysts' average estimate of $5.36 billion

** Adjusted earnings of 58 cents per share, above the average estimate of 56 cents

** Company raises 2014 forecast for adjusted earnings

** U.S.-listed shares at $45.95, Toronto-listed shares at C$51.48